Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Patent CN115286629B details a magnetic catalytic route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable production capabilities.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Patent CN106946875A details green synthesis for high-purity imidazole intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel chiral phosphoric acid catalyzed synthesis of indolocyclopentanes with high enantioselectivity. Cost-effective route for pharmaceutical intermediates targeting PC-3 cancer cells.
Patent CN115057848B reveals a mild chiral synthesis route for high-purity axial chiral isopyrone-indole derivatives, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Patent CN108558692B reveals a mild N-heterocyclic carbene catalyzed route for amide bond formation, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN118878543A reveals high-purity axial chiral synthesis. Delivers significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN111100085A reveals a green DES-based synthesis for benzoxazine derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering high yields and simplified supply chains for pharmaceutical manufacturing.
Patent CN109265403B reveals a novel benzimidazole synthesis method using imidazole hydrochloride, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Patent CN110092751B reveals a green one-pot method for 2-alkyl quinolines using montmorillonite and iodine, offering significant cost reduction and supply chain stability.
Patent CN115304557B reveals low-cost manganese catalysis for enamine synthesis, offering high yield and scalable pharmaceutical intermediate manufacturing solutions.
Novel chiral phosphoric acid catalyzed synthesis offers high optical purity and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Novel synthesis of axial chiral arylindole compounds via chiral phosphoric acid. High optical purity for pharmaceutical intermediates manufacturing.